Capella Biosciences | CapellaBio | Precise Medicine from Data | CEO Pek Lum | Palo Alto California

Press Release

Stem Cell Theranostics and CapellaBio Announce Cardio-Oncology Collaboration and Discovery of Novel Class of Cardioprotective Drug Therapies

Combining a computational biomedicine approach with advanced iPSC-derived preclinical models promises to dramatically accelerate the discovery of novel therapies, said Chris Armstrong, CEO of Stem Cell Theranostics. In less than 6 months, our collaboration with CapellaBio has led to the discovery and validation of several promising cardioprotectant drug leads with best-in-class properties. .... Full Article

A VC funded computational pharmaceutical company based in Silicon Valley